# OnCo record nct05935748 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05935748/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05935748", "NCT05935748" ;
  schema:name "Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)"@en ;
  schema:description "A phase 2 trial of NKT2152 run by NiKang Therapeutics, Inc., terminated."@en ;
  schema:url <https://onco.cc/trials/nct05935748/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05935748> ;
  onco:status "historic" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/clear-cell-rcc/> ;
  onco:drugs <https://onco.cc/drugs/nkt2152/> ;
  onco:companies <https://onco.cc/companies/nikang-therapeutics/> .